Viztek introduced fully equipped mobile imaging vehicles, which includes a Honda Element equipped with Viztek Opal-RAD PACS and Kodak Point-of-Care CR, providing radiology groups with a turnkey solution to broaden their patient base, also making diagnostic imaging accessible in impoverished areas.

Acusphere has submitted a New Drug Application (NDA) to the FDA for approval to market Imagify (Perflubutane Polymer Microspheres for Injectable Suspension), an ultrasound imaging agent for the detection of coronary artery disease, which could prove as accurate as nuclear stress testing.

ProHance is a macrocyclic, nonionic, gadolinium-based magnetic resonance imaging (MRI) contrast agent designed for use in MRI in adults and children over two years of age to visualize lesions with abnormal vascularity in the brain (intracranial lesions), spine and associated tissues. ProHance is also indicated for use in MRI in adults to visualize lesions in the head and neck.